These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25000442)

  • 1. Comparison of quality of life in patients with peripheral arterial disease caused by atherosclerosis obliterans or Buerger's disease.
    Karakoyun R; Köksoy C; Şener Z; Gündüz U; Karakaş B; Karakoyun M
    Cardiovasc J Afr; 2014; 25(3):124-9. PubMed ID: 25000442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lumbar sympathectomy versus prostanoids for critical limb ischaemia due to non-reconstructable peripheral arterial disease.
    Sen I; Agarwal S; Tharyan P; Forster R
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD009366. PubMed ID: 29658630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological treatment for Buerger's disease.
    Cacione DG; Macedo CR; do Carmo Novaes F; Baptista-Silva JC
    Cochrane Database Syst Rev; 2020 May; 5(5):CD011033. PubMed ID: 32364620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological treatment for Buerger's disease.
    Cacione DG; Baptista-Silva JC; Macedo CR
    Cochrane Database Syst Rev; 2016 Feb; 2():CD011033. PubMed ID: 26828199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical properties in the patients with Buerger's disease--possible role of plasminogen activator inhibitor-1 for preservation of vessel wall architecture.
    Sato T; Tamai H; Kobayashi M; Yamamoto K; Komori K
    Cardiovasc Pathol; 2011; 20(5):266-71. PubMed ID: 20708412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Efficacy of Percutaneous Transluminal Angioplasty on the Limb Salvage and Recovery of Symptoms in Patients With Buerger's Disease With Critical Limb Ischemia.
    Rodoplu O; Yildiz CE; Oztas DM; Conkbayir C; Unal O; Ulukan MO; Meric M; Ugurlucan M; Kirbas A
    J Invasive Cardiol; 2020 Jun; 32(6):E158-E167. PubMed ID: 32479418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting the long-term outcome of Buerger's disease (thromboangiitis obliterans).
    Shigematsu H; Shigematsu K
    Int Angiol; 1999 Mar; 18(1):58-64. PubMed ID: 10392482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cell therapy for treatment of thromboangiitis obliterans (Buerger's disease).
    Cacione DG; do Carmo Novaes F; Moreno DH
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD012794. PubMed ID: 30378681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decrease in prevalence of Buerger's disease in Japan.
    Matsushita M; Nishikimi N; Sakurai T; Nimura Y
    Surgery; 1998 Sep; 124(3):498-502. PubMed ID: 9736901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombangiitis obliterans (Buerger's disease): still a limb threatening disease.
    Van Damme H; De Leval L; Creemers E; Limet R
    Acta Chir Belg; 1997 Oct; 97(5):229-36. PubMed ID: 9394964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comprehensive treatment of a patient with Buerger's disease using genetically engineered complexes VEGF-165].
    Gavrilenko AV; Oleĭnik EM
    Angiol Sosud Khir; 2019; 25(1):177-180. PubMed ID: 30994625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Multiple brain infarctions in a young patient with Buerger's disease. A case report of cerebral thromboangiitis obliterans].
    Rai M; Miyashita K; Oe H; Nishigami K; Naritomi H
    Rinsho Shinkeigaku; 2004 Aug; 44(8):522-6. PubMed ID: 15471087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Iranian scoring system for diagnosing Buerger's disease.
    Ramin M; Salimi J; Meysamie A
    Acta Med Iran; 2014 Feb; 52(1):60-5. PubMed ID: 24658990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term clinical outcome after intramuscular transplantation of granulocyte colony stimulating factor-mobilized CD34 positive cells in patients with critical limb ischemia.
    Kinoshita M; Fujita Y; Katayama M; Baba R; Shibakawa M; Yoshikawa K; Katakami N; Furukawa Y; Tsukie T; Nagano T; Kurimoto Y; Yamasaki K; Handa N; Okada Y; Kuronaka K; Nagata Y; Matsubara Y; Fukushima M; Asahara T; Kawamoto A
    Atherosclerosis; 2012 Oct; 224(2):440-5. PubMed ID: 22877866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease in the incidence of Buerger's disease recurrence in northern Thailand.
    Laohapensang K; Rerkasem K; Kattipattanapong V
    Surg Today; 2005; 35(12):1060-5. PubMed ID: 16341487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Transpedal Retrograde Approach in Endovascular Treatment of Patients With Buerger's Disease.
    Tatli E; Buturak A; Vatan MB; Kurt Ömürlü I; Erkin A
    J Invasive Cardiol; 2023 Feb; 36(2):E84-E91. PubMed ID: 36562796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The change in concept and surgical treatment on Buerger's disease--personal experience and review.
    Nakajima N
    Int J Cardiol; 1998 Oct; 66 Suppl 1():S273-80; discussion S281. PubMed ID: 9951830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular function and circulating progenitor cells in thromboangitis obliterans (Buerger's disease) and atherosclerosis obliterans.
    Idei N; Nishioka K; Soga J; Hidaka T; Hata T; Fujii Y; Fujimura N; Maruhashi T; Mikami S; Teragawa H; Kihara Y; Noma K; Chayama K; Higashi Y
    Hypertension; 2011 Jan; 57(1):70-8. PubMed ID: 21115876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does a species of Rickettsia play a role in the pathophysiology of Buerger's disease?
    Fazeli B; Ravari H; Farzadnia M
    Vascular; 2012 Dec; 20(6):334-6. PubMed ID: 21803838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distal ischemia with digital gangrene secondary to Buerger's disease.
    Lance BJ; Kirschenbaum SE
    J Foot Surg; 1991; 30(6):534-41. PubMed ID: 1770204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.